World Hemophilia Day

Author: Turacoz Group
April 17, 2016

Let’s Join Hands to Fight Against Hemophilia

Hemophilia is one of the oldest known genetic bleeding disorder which is caused by deficiency of the genes responsible for synthesis of clotting factors. Clotting factors are special type of proteins required for blood clotting. If a person does not have enough clotting factor VIII, then the condition is known as “hemophilia A”, while deficiency of clotting factor IX is known as “hemophilia B”.

Misconception                Individuals with hemophilia bleed faster than normal people

    Fact                             Individuals with hemophilia bleed longer than normal people

 

The major symptoms of hemophilia are: prolonged bleeding, spontaneous bleeding, bleeding into joints and muscles, excessive bleeding following trauma or surgery, easy bruising, swelling, pain, and stiffness. Left untreated, it can lead to various life-threatening complications like deep internal bleedings, joint damage, and intracranial hemorrhage. However, there are various treatment options available for the disorder like replacement therapy with clotting factors, gene therapy and anti-fibrinolytic medicines. Unfortunately, a large population of hemophilic patients is unable to receive adequate treatment due to its high cost.

Although the incidence of hemophilia is low and is estimated to affect approximately 1 in 10,000 people, only 25 % of those living with hemophilia get proper care.

 

World Hemophilia Day (WHD) is, therefore, a day to consider those hemophilic patients who are unable to access the care and treatment they require to live a healthy life.

History: WHD was established in 1989 with the help of the World Federation of Hemophilia (WFH). Since 1989, WHD is observed globally on April 17 in order to honor Frank Schnabel, the founder of WFH, whose birthday falls on the same date. Today, WHD has grown into a global event which is celebrated across 113 WFH member countries.

 

“Treatment for all is the vision of all” is the main goal of WHD.

The main aim of WHD is to increase public awareness, educate patients, attract volunteers, and advocate for improved treatment and care of hemophilia. This day provides an opportunity to talk to your family, friends, and colleagues to raise awareness and increase support for the patients living with hemophilia and other bleeding disorders.

A patient with hemophilia must be encouraged to think and act positively. Since hemophilia is a lifelong condition, requires expensive treatment, and affects patient’s family life, therefore, it is important that parents, spouses, and other family members of the patient should be educated in all aspects of the patient’s care. Besides, general information and education should also be given to the community where hemophilic patient lives.

Today, someone born with hemophilia can live a normal life if he/she has access to adequate treatment. Although access to adequate treatment is a big challenge but the WFH has a vision and is trying hard to provide treatment for all the people with hemophilia.

Tags:

You Might Also Like

  • Top Benefits of Using Academic Research Writing Services

    “Write the paper as though no editor will ever see it … then let a good editor make sure everyone

  • World Thyroid Day 2025: How AI Is Revolutionizing Thyroid Health

    World Thyroid Day invites us to appreciate the tiny, butterfly-shaped gland with a big job in managing our body’s energy,

  • How AI is redefining content creation in pharma — And why humans are still the drivers of trust

    In an era where speed, efficiency, and personalization have become imperatives, Artificial Intelligence (AI) — particularly machine learning, AI algorithms,

  • World Thalassemia Day 2025: Giving a Voice to the Global Patient Community

    Every 8 May, World Thalassemia Day shines an international spotlight on the millions of people living with this inherited genetic disorder.

  • Decoding Ovarian Cancer Symptoms: Communicating the Silent Signs

    Ovarian cancer remains one of the most challenging gynaecologic malignancies, often referred to as a “silent killer” due to its subtle onset and late-stage diagnosis.1 In 2022, 324,603 women worldwide were diagnosed with ovarian cancer.

  • 4 Ways in Which HEOR is Transforming Healthcare with RWE

    The healthcare landscape is being reshaped at an unprecedented pace, powered by sophisticated data analytics, emerging technologies, and the escalating

  • The Role of HEOR in Payer Decisions to Switch from Originators to Biosimilars

    Biosimilars—biologic medicines that are highly similar to FDA-approved originator biologics—offer a cost-effective alternative without compromising clinical efficacy.1,2 Since the first

  • Content’s Industrial Revolution: Shaping the Future of Pharma

    Communications In a rapidly evolving digital ecosystem, the pharmaceutical industry’s relationship with content is undergoing a seismic shift. At the

  • Health Journalism: Combating Misinformation with Accuracy

    By Turacoz Healthcare Solutions | World Liver Day 2025 In a world where social media dominates wellness discussions, liver health

  • Patient Voices Matter: How Patient-reported Outcomes Are Redefining Market Access

    The healthcare industry is experiencing a paradigm shift as patient voices take center stage in drug development and approval processes.

Newsletter

Stay informed with the latest trends, insights, and updates in medical communications—download our newsletter now.

partner with us

Partner with Turacoz to bring science to life through strategic and evidence-based communication.

Partner with Us